Log in
Enquire now
‌

ApoGen Biotechnologies

ApoGen Biotechnologies is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
Company Operating Status
Active
Country
United States
United States
0
Email Address
info@apogenbiotech.com
0
Fax Number
+12069577399
0
Founder
‌
Reuben Harris
0
‌
Daniel Harki
0
John Santini
John Santini
0
Full Address
2815 Eastlake Avenue East, Suite 300 Seattle, WA 98102
0
Industry
Cancer
Cancer
Oncology
Oncology
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Internal medicine
Internal medicine
Healthcare
Healthcare
Medicine
Medicine
Biopharmaceutical
Biopharmaceutical
Investors
Lilly Ventures
Lilly Ventures
0
Alexandria Venture Investments
Alexandria Venture Investments
0
WuXi AppTec
WuXi AppTec
0
‌
Watson Fund
0
ARCH Venture Partners
ARCH Venture Partners
0
WRF Capital
WRF Capital
0
AbbVie Inc.
AbbVie Inc.
0
Latest Funding Round Date
December 13, 2016
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/apogen-biotechnologies-inc-
Location
Seattle
Seattle
0
Phone Number
+12069577300
0
Pitchbook URL
pitchbook.com/profiles...150156-64
Total Funding Amount (USD)
7,000,000
Official Website
apogenbiotech.com

Find more companies like ApoGen Biotechnologies

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.